Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 40 mg/mL, 1 mL single-dose vial, Rx only, MFG: Pfizer, NDC 0009-3073-03
Check against the official notice below — it lists the full affected range.
McKesson Medical-Surgical Inc. is recalling Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 40 mg/mL in 1 mL single-dose vials manufactured by Pfizer due to temperature abuse during storage that violates good manufacturing practice requirements. The recall affects 2 cartons distributed nationwide across the United States. Because McKesson is unable to identify which specific lot number was received by individual customers, each notification letter includes the distribution date and the dates when affected product may have been shipped to that particular customer.
The source document does not specify a remedy or what consumers should do in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
cGMP deviations: Temperature abuse
Reason for recall: cGMP deviations: Temperature abuse Distribution: USA nationwide. Quantity: 2 cartons Lot/code info: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.